Paper24944404
Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.
Hayamizu K and 9 others. Curr Ther Res Clin Exp, 2003. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial. Papers, record 24944404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24944404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4815799 | Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. | Lipids | 1974 | https://conductscience.org/library/papers/4815799 | PubMed |
| 2 | 8624176 | Overweight, underweight, and mortality. A prospective study of 48,287 men and women. | Arch Intern Med | 1996 | https://conductscience.org/library/papers/8624176 | PubMed |
| 3 | 8581775 | Pathophysiology and pathogenesis of visceral fat obesity. | Obes Res | 1995 | https://conductscience.org/library/papers/8581775 | PubMed |
| 4 | 334761 | Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase. | J Biol Chem | 1977 | https://conductscience.org/library/papers/334761 | PubMed |
| 5 | 4815800 | Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. | Lipids | 1974 | https://conductscience.org/library/papers/4815800 | PubMed |
| 6 | 4062128 | Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/4062128 | PubMed |
| 7 | 8641026 | Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. | Circulation | 1996 | https://conductscience.org/library/papers/8641026 | PubMed |
| 8 | 19094306 | Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. | Nutr Res Rev | 1993 | https://conductscience.org/library/papers/19094306 | PubMed |
| 9 | 3795418 | Body weight and longevity. A reassessment. | JAMA | 1987 | https://conductscience.org/library/papers/3795418 | PubMed |
| 10 | 6971814 | The health consequences of moderate obesity. | Int J Obes | 1981 | https://conductscience.org/library/papers/6971814 | PubMed |
| 11 | 3056758 | Banting lecture 1988. Role of insulin resistance in human disease. | Diabetes | 1988 | https://conductscience.org/library/papers/3056758 | PubMed |
| 12 | 324261 | Metabolic regulation as a control for lipid disorders. I. Influence of (--)-hydroxycitrate on experimentally induced obesity in the rodent. | Am J Clin Nutr | 1977 | https://conductscience.org/library/papers/324261 | PubMed |
| 13 | 4062125 | Complications of obesity. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/4062125 | PubMed |
| 14 | 5362924 | Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase. | Arch Biochem Biophys | 1969 | https://conductscience.org/library/papers/5362924 | PubMed |
| 15 | 2643000 | Health risks of obesity. | Med Clin North Am | 1989 | https://conductscience.org/library/papers/2643000 | PubMed |
| 16 | 691146 | Weight and blood pressure. Findings in hypertension screening of 1 million Americans. | JAMA | 1978 | https://conductscience.org/library/papers/691146 | PubMed |
| 17 | 9820262 | Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. | JAMA | 1998 | https://conductscience.org/library/papers/9820262 | PubMed |
| 18 | 389027 | Obesity: adverse effects on health and longevity. | Am J Clin Nutr | 1979 | https://conductscience.org/library/papers/389027 | PubMed |
| 19 | 7980698 | Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. | Atherosclerosis | 1994 | https://conductscience.org/library/papers/7980698 | PubMed |
| 20 | 5542676 | Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. | J Biol Chem | 1971 | https://conductscience.org/library/papers/5542676 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42182939 | A rank-based robust change-point regression approach in human intervention studies of functional foods. | J Clin Biochem Nutr | 2026 | https://conductscience.org/library/papers/42182939 | PubMed |
| 41754218 | Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clinically Studied Weight-Management Supplements in Obesity. | Nutrients | 2026 | https://conductscience.org/library/papers/41754218 | PubMed |
| 40869311 | Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869311 | PubMed |
| 40336110 | Lipid-based nano-carriers for the delivery of anti-obesity natural compounds: advances in targeted delivery and precision therapeutics. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40336110 | PubMed |
| 38074292 | DNA barcode identification of cultivated and wild tropical fruit species. | 3 Biotech | 2024 | https://conductscience.org/library/papers/38074292 | PubMed |
| 38053822 | Cydonia oblonga Miller fruit extract exerts an anti-obesity effect in 3T3-L1 adipocytes by activating the AMPK signaling pathway. | Nutr Res Pract | 2023 | https://conductscience.org/library/papers/38053822 | PubMed |
| 37575813 | Weight Loss or Liver Loss: A Case Report on Fulminant Hepatic Failure Secondary to Garcinia cambogia Supplementation. | Cureus | 2023 | https://conductscience.org/library/papers/37575813 | PubMed |
| 37297447 | Anti-Obesity Effects of SPY Fermented with Lactobacillus rhamnosus BST-L.601 via Suppression of Adipogenesis and Lipogenesis in High-Fat Diet-Induced Obese Mice. | Foods | 2023 | https://conductscience.org/library/papers/37297447 | PubMed |
| 37050928 | Garcinia cambogia water extract alleviates insulin resistance and hepatic lipid accumulation in mice fed a high-fat diet. | Food Nutr Res | 2023 | https://conductscience.org/library/papers/37050928 | PubMed |
| 35547650 | A clinical and computational study on anti-obesity effects of hydroxycitric acid. | RSC Adv | 2019 | https://conductscience.org/library/papers/35547650 | PubMed |
| 35418711 | Development and Validation of an Analytical Method to Quantitate Hydroxycitric Acid, the Key Constituent in Garcinia cambogia Extract, in Rodent Plasma and Fetus. | Anal Lett | 2022 | https://conductscience.org/library/papers/35418711 | PubMed |
| 34552954 | Caloric Restriction Mimetics in Nutrition and Clinical Trials. | Front Nutr | 2021 | https://conductscience.org/library/papers/34552954 | PubMed |
| 34400337 | Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/34400337 | PubMed |
| 34249131 | Antioxidant and Antimicrobial Activities of the Extracts from Different Garcinia Species. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34249131 | PubMed |
| 34159755 | A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss. | Obesity (Silver Spring) | 2021 | https://conductscience.org/library/papers/34159755 | PubMed |
| 33572973 | Risks Associated with the Use of Garcinia as a Nutritional Complement to Lose Weight. | Nutrients | 2021 | https://conductscience.org/library/papers/33572973 | PubMed |
| 33460282 | Mass spectrometric investigations of caloric restriction mimetics. | Proteomics | 2021 | https://conductscience.org/library/papers/33460282 | PubMed |
| 32962190 | Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review. | Nutrients | 2020 | https://conductscience.org/library/papers/32962190 | PubMed |
| 32354172 | Organic Acids from Roselle (Hibiscus sabdariffa L.)-A Brief Review of Its Pharmacological Effects. | Biomedicines | 2020 | https://conductscience.org/library/papers/32354172 | PubMed |
| 30354100 | Phloroglucinols from the Roots of Garcinia dauphinensis and Their Antiproliferative and Antiplasmodial Activities. | J Nat Prod | 2019 | https://conductscience.org/library/papers/30354100 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24944404
GET https://conductscience.org/api/papers/v1/24944404/references?page=2